Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (231-240 of 362) with videos related to

Pageof 37
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|June 10, 2022
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatmentKatarzyna Furrer, Walter Weder, Eric Innocents Eboulet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and BiomarkersSolange Peters, Rolf Stahel, Lukas Bubendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectivesJulien Mazières, Solange Peters, Benoit Lepage, et al.
Scientific Reports|October 23, 2021
Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLCDiem Vuong, Marta Bogowicz, Leonard Wee, et al.
Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 24, 2019
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX StudyD Ross Camidge, Rafal Dziadziuszko, Solange Peters, et al.
Frontiers in Oncology|December 26, 2022
A differential process mining analysis of COVID-19 management for cancer patientsMichel A Cuendet, Roberto Gatta, Alexandre Wicky, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2011
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)Gianfranco A Pesce, Dirk Klingbiel, Karin Ribi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parametersSolange Peters, Walter Weder, Urania Dafni, et al.
JACC. Cardiooncology|June 17, 2026
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related MyocarditisDouglas Daoudlarian, Sarah Boughdad, Robin Bartolini, et al.
Pageof 37

Showing results (231-240 of 362) with videos related to

Sort By:
Pageof 37
The Journal of Thoracic and Cardiovascular Surgery|June 10, 2022
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatmentKatarzyna Furrer, Walter Weder, Eric Innocents Eboulet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and BiomarkersSolange Peters, Rolf Stahel, Lukas Bubendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectivesJulien Mazières, Solange Peters, Benoit Lepage, et al.
Scientific Reports|October 23, 2021
Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLCDiem Vuong, Marta Bogowicz, Leonard Wee, et al.
Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 24, 2019
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX StudyD Ross Camidge, Rafal Dziadziuszko, Solange Peters, et al.
Frontiers in Oncology|December 26, 2022
A differential process mining analysis of COVID-19 management for cancer patientsMichel A Cuendet, Roberto Gatta, Alexandre Wicky, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2011
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)Gianfranco A Pesce, Dirk Klingbiel, Karin Ribi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parametersSolange Peters, Walter Weder, Urania Dafni, et al.
JACC. Cardiooncology|June 17, 2026
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related MyocarditisDouglas Daoudlarian, Sarah Boughdad, Robin Bartolini, et al.
Pageof 37